Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.

GOTHENBURG, Sweden, May 28, 2026 /PRNewswire/ -- Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed Inc ("Abiomed") in a patent dispute between Getinge's subsidiary Maquet Cardiovascular LLC ("Maquet") and Abiomed. The jury found that Abiomed has not infringed any Maquet patents relating to intravascular heart pump technology.